Literature DB >> 18583323

YKL-40: a candidate biomarker for simian immunodeficiency virus and human immunodeficiency virus encephalitis?

Dennis L Kolson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18583323      PMCID： PMC2438282          DOI： 10.2353/ajpath.2008.080389

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  31 in total

1.  CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS.

Authors:  Eliseo A Eugenin; Kristin Osiecki; Lillie Lopez; Harris Goldstein; Tina M Calderon; Joan W Berman
Journal:  J Neurosci       Date:  2006-01-25       Impact factor: 6.167

2.  Early brain injury in the SIV-macaque model of AIDS.

Authors:  R G González; L L Cheng; S V Westmoreland; K E Sakaie; L R Becerra; P L Lee; E Masliah; A A Lackner
Journal:  AIDS       Date:  2000-12-22       Impact factor: 4.177

3.  Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia.

Authors:  J J Sevigny; S M Albert; M P McDermott; J C McArthur; N Sacktor; K Conant; G Schifitto; O A Selnes; Y Stern; D R McClernon; D Palumbo; K Kieburtz; G Riggs; B Cohen; L G Epstein; K Marder
Journal:  Neurology       Date:  2004-12-14       Impact factor: 9.910

4.  CSF amyloid beta42 and tau levels correlate with AIDS dementia complex.

Authors:  B J Brew; L Pemberton; K Blennow; A Wallin; L Hagberg
Journal:  Neurology       Date:  2005-11-08       Impact factor: 9.910

5.  Plasma levels of soluble CD14 and tumor necrosis factor-alpha type II receptor correlate with cognitive dysfunction during human immunodeficiency virus type 1 infection.

Authors:  L A Ryan; J Zheng; M Brester; D Bohac; F Hahn; J Anderson; W Ratanasuwan; H E Gendelman; S Swindells
Journal:  J Infect Dis       Date:  2001-08-15       Impact factor: 5.226

6.  HIV-associated cognitive impairment before and after the advent of combination therapy.

Authors:  Ned Sacktor; Michael P McDermott; Karen Marder; Giovanni Schifitto; Ola A Selnes; Justin C McArthur; Yaakov Stern; Steve Albert; Donna Palumbo; Karl Kieburtz; Joy A De Marcaida; Bruce Cohen; Leon Epstein
Journal:  J Neurovirol       Date:  2002-04       Impact factor: 2.643

7.  Longitudinal analysis of monocyte/macrophage infection in simian immunodeficiency virus-infected, CD8+ T-cell-depleted macaques that develop lentiviral encephalitis.

Authors:  Stephanie J Bissel; Guoji Wang; Anita M Trichel; Michael Murphey-Corb; Clayton A Wiley
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

Review 8.  Novel markers of oxidative stress in actively progressive HIV dementia.

Authors:  Ned Sacktor; Norman Haughey; Roy Cutler; Anita Tamara; Jadwiga Turchan; Carlos Pardo; Diana Vargas; Avindra Nath
Journal:  J Neuroimmunol       Date:  2004-12       Impact factor: 3.478

Review 9.  Serum YKL-40, a new prognostic biomarker in cancer patients?

Authors:  Julia S Johansen; Benny Vittrup Jensen; Anne Roslind; Dorte Nielsen; Paul A Price
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-02       Impact factor: 4.254

10.  YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor.

Authors:  Dafna Bonneh-Barkay; Stephanie J Bissel; Gouji Wang; Kenneth N Fish; Georgina C B Nicholl; Samuel W Darko; Rafael Medina-Flores; Michael Murphey-Corb; Premeela A Rajakumar; Julia Nyaundi; John W Mellors; Robert Bowser; Clayton A Wiley
Journal:  Am J Pathol       Date:  2008-06-13       Impact factor: 4.307
View more
  3 in total

1.  Cerebrospinal Fluid Biomarkers of Simian Immunodeficiency Virus Encephalitis : CSF Biomarkers of SIV Encephalitis.

Authors:  Stephanie J Bissel; Julia Kofler; Julia Nyaundi; Michael Murphey-Corb; Stephen R Wisniewski; Clayton A Wiley
Journal:  J Neuroimmune Pharmacol       Date:  2016-04-08       Impact factor: 4.147

Review 2.  HIV/neuroAIDS biomarkers.

Authors:  Pejman Rahimian; Johnny J He
Journal:  Prog Neurobiol       Date:  2016-04-12       Impact factor: 11.685

3.  Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease.

Authors:  Richard J Perrin; Rebecca Craig-Schapiro; James P Malone; Aarti R Shah; Petra Gilmore; Alan E Davis; Catherine M Roe; Elaine R Peskind; Ge Li; Douglas R Galasko; Christopher M Clark; Joseph F Quinn; Jeffrey A Kaye; John C Morris; David M Holtzman; R Reid Townsend; Anne M Fagan
Journal:  PLoS One       Date:  2011-01-12       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.